News

Applied Clinical Trials Online4h
Otsuka’s Sibeprenlimab Demonstrates Meaningful Outcomes in Phase III Study for Immunoglobulin A Nephropathy
In the Phase III VISIONARY study, sibeprenlimab, an investigational monoclonal antibody, showed a 51.2% reduction in ...
Applied Clinical Trials Online5h
Phase III IRAKLIA and Phase II IZALCO Trials Support Sarclisa On-Body Delivery for Relapsed/Refractory Multiple Myeloma
New data from the IRAKLIA and IZALCO trials, presented at the 2025 ASCO Annual Meeting, demonstrate that subcutaneous ...